Pharmaceutical

INDUSTRY LEADER IN PATIENT CENTRICITY CALLS FOR ITS SYSTEM-WIDE ADOPTION IN NEW BOOK

Dr. Anthony Yanni publishes a wide-ranging case for patient-centered healthcare delivery and treatment development—a "long-overdue disruption." SCRANTON, Pa., June 25,…

7 months ago

Physician’s Weekly and Figure 1 Strengthen HCP Engagement With Creation of New Parent Company Formedics

– Under Formedics, Physician's Weekly and Figure 1 retain their own names and brands – – Formedics launches with an…

7 months ago

Virtusa secures SIIA CODiE Award for Best Healthcare Technology Solution

SOUTHBOROUGH, Mass., June 25, 2024 /PRNewswire/ -- Virtusa Corporation, a global provider of digital strategy, digital engineering, and IT services and…

7 months ago

Slope Spearheads Launch of Biospecimen Management Consortium to Drive Sample Excellence in Clinical Research

GRAIL, GSK, ILiAD, Moderna, Novartis, Roche, Takeda, and Teal Health join as founding members RICHMOND, Va., June 25, 2024 /PRNewswire/…

7 months ago

Metabolon Receives NIH Grant to Develop Advanced Monitoring and Predictive Tools for Type 1 Diabetes Progression

MORRISVILLE, N.C., June 25, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of…

7 months ago

ToxStrategies Acquires Clintrex Research Corporation

Partnership between leading scientific service providers enhances offerings for pharmaceutical clients KATY, Texas, June 25, 2024 /PRNewswire/ -- ToxStrategies, a best-in-class,…

7 months ago

NervGen Pharma to Advance NVG-300 into Preclinical Proof-of-Concept Stage

New molecule demonstrates efficacy in a challenging SCI modelExpanding pipeline into new indications of ischemic stroke and ALSVancouver, British Columbia--(Newsfile…

7 months ago

Health Canada Issues Three Export Permits to Optimi to Supply Patients Under Australia’s Authorised Prescriber Scheme

The Company will ship 160 doses of MDMA and psilocybin to Australian psychiatrists for the treatment of patients with PTSD…

7 months ago

Nasdaq Panel Grants NLS Pharmaceutics’ Request for Extension to Comply with Continued Listing Requirements

ZURICH, SWITZERLAND / ACCESSWIRE / June 25, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a leading Swiss…

7 months ago

Oragenics, Inc. Announces Pricing of Public Offering

SARASOTA, Fla., June 25, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal…

7 months ago